Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 12 open reading frame 75 (C12orf75), also known as Overexpressed in colon carcinoma 1 protein (OCC-1) and adipogenesis down-regulated 3 (AGD3), encodes a protein of currently unclear function, originally discovered due to its high expression in colorectal cancer. C12orf75 expression is elevated in several human tumors (including bladder and liver carcinoma) and associated with poor prognosis in these cancers, although the functional role may vary and in some cancers it is associated with either promotion or inhibition of tumor progression. Early studies indicated a role in adipocyte differentiation, while later analyses show links to the tumor microenvironment, immune infiltration, and cancer cell proliferation or apoptosis. C12orf75 is not a classical receptor, enzyme, ion channel, transporter, or transcription factor, and its precise molecular function remains to be clarified. There are no approved drugs directly targeting C12orf75, and no established therapeutic mechanisms or safety concerns specific to this gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 12 open reading frame 75 (C12orf75).